Carl Dockery - Net Worth and Insider Trading

Carl Dockery Net Worth

The estimated net worth of Carl Dockery is at least $367,464 dollars as of 2024-09-20. Carl Dockery is the Director, 10% Owner of CytoDyn Inc and owns about 2,236,543 shares of CytoDyn Inc (CYDY) stock worth over $367,464. Details can be seen in Carl Dockery's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Dockery has not made any transactions after 2015-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carl Dockery

To

Carl Dockery Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carl Dockery owns 3 companies in total, including Aytu BioPharma Inc (AYTU) , CytoDyn Inc (CYDY) , and Rezolute Inc (RZLT) .

Click here to see the complete history of Carl Dockery’s form 4 insider trades.

Insider Ownership Summary of Carl Dockery

Ticker Comapny Transaction Date Type of Owner
AYTU Aytu BioPharma Inc 2023-08-11 director
CYDY CytoDyn Inc 2015-06-05 director & 10 percent owner
RZLT Rezolute Inc 2014-04-01 other: See remarks

Carl Dockery Latest Holdings Summary

Carl Dockery currently owns a total of 1 stock. Carl Dockery owns 2,236,543 shares of CytoDyn Inc (CYDY) as of June 5, 2015, with a value of $367,464.

Latest Holdings of Carl Dockery

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYDY CytoDyn Inc 2015-06-05 2,236,543 0.16 367,464

Holding Weightings of Carl Dockery


Carl Dockery Form 4 Trading Tracker

According to the SEC Form 4 filings, Carl Dockery has made a total of 0 transactions in CytoDyn Inc (CYDY) over the past 5 years. The most-recent trade in CytoDyn Inc is the acquisition of 140,843 shares on June 5, 2015, which cost Carl Dockery around $70,422.

Insider Trading History of Carl Dockery

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carl Dockery Trading Performance

GuruFocus tracks the stock performance after each of Carl Dockery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl Dockery is -17.39%. GuruFocus also compares Carl Dockery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl Dockery within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Carl Dockery's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Carl Dockery

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.52 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.75 LIMIT LIMIT LIMIT LIMIT LIMIT

Carl Dockery Ownership Network

Ownership Network List of Carl Dockery

No Data

Ownership Network Relation of Carl Dockery

Insider Network Chart

Carl Dockery Owned Company Details

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Carl Dockery is the director of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Carl Dockery made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 14,000 shares made by Joshua R. Disbrow ,

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 14,000 shares were bought by its insiders, resulting in a net purchase of 14,000 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aytu BioPharma Inc Insider Transactions

No Available Data

Carl Dockery Mailing Address

Above is the net worth, insider trading, and ownership report for Carl Dockery. You might contact Carl Dockery via mailing address: P.o. Box 2477, Lakeland Fl 33806-2477.

Discussions on Carl Dockery

No discussions yet.